FUCIDIN Trademark

Trademark Overview

On Tuesday, August 25, 2020, a trademark application was filed for FUCIDIN with the United States Patent and Trademark Office. The USPTO has given the FUCIDIN trademark a serial number of 90134982. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, August 11, 2023. This trademark is owned by Mercury Pharma Group Limited. The FUCIDIN trademark is filed in the Pharmaceutical Products category with the following description:

Ophthalmological preparations
fucidin

General Information

Serial Number90134982
Word MarkFUCIDIN
Filing DateTuesday, August 25, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, August 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 26, 2021

Trademark Statements

Goods and ServicesOphthalmological preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMercury Pharma Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon EC4N7BL
GB
Party NameMercury Pharma Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon EC4N7BL

Trademark Events

Event DateEvent Description
Saturday, August 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 11, 2023SOU EXTENSION 5 GRANTED
Friday, August 4, 2023SOU EXTENSION 5 FILED
Friday, August 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2023SOU EXTENSION 4 GRANTED
Monday, February 27, 2023SOU EXTENSION 4 FILED
Monday, February 27, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2022SOU EXTENSION 3 GRANTED
Friday, September 16, 2022SOU EXTENSION 3 FILED
Friday, September 16, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 25, 2022SOU EXTENSION 2 GRANTED
Friday, February 25, 2022SOU EXTENSION 2 FILED
Friday, February 25, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 20, 2021SOU EXTENSION 1 GRANTED
Monday, September 20, 2021SOU EXTENSION 1 FILED
Monday, September 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 17, 2020ASSIGNED TO EXAMINER
Monday, September 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 28, 2020NEW APPLICATION ENTERED

Related Keywords

fucidin preparations ophthalmological